Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)

Summary

A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression.

Timeline

Start

2002-06-18

Primary completion

2003-10-03

Completion

2003-10-03

Publications

• Background Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G, Hargreaves R, Hietala J, Lines C, Beebe K, Reines S. Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry. 2006 Feb 1;59(3):216-23. doi: 10.1016/j.biopsych.2005.07.013. Epub 2005 Oct 24.

Drugs

Indications